Stryker Makes $400 Million Preferred Equity Investment in CMR Surgical
October 12, 2026
Stryker agreed to invest approximately $400 million in CMR Surgical through preferred equity, with an exclusive option to acquire the company’s remaining equity in the future. The strategic alliance also makes Stryker the exclusive U.S. sales agent for CMR’s Versius portfolio, while CMR retains product development and commercialization outside the United States.
- Buyers
- Stryker
- Targets
- CMR Surgical
- Industry
- Medical Devices
- Location
- United Kingdom
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.